Literature DB >> 6790402

Thyrotropin-releasing hormone increases plasma norepinephrine in man.

J E Morley, M L Tuck, D M Mayes, S Rosenblatt, J M Hershman.   

Abstract

Administration of exogenous thyrotropin-releasing hormone (TRH) in man leads to an increase in mean arterial blood pressure at 4 and 8 min after TRH. This increase in mean arterial blood pressure is preceded by an increase in plasma norepinephrine levels (maximum response of 274 +/- 42 pg/ml vs. basal 158 +/- 32, p less than 0.01). There was a nonsignificant tendency for epinephrine levels to rise. There was no alteration in plasma renin activity (basal 1.2 +/- 0.4 ng/ml/min vs. peak 1.4 +/- 0.3) or in plasma aldosterone (basal 5.0 +/- 0.6 ng/dl vs. peak 6.8 +/- 0.7). We conclude that TRH causes an increase in blood levels of catecholamines in normal man through undetermined mechanisms. The blood pressure changes associated with TRH administration may be related to norepinephrine release. Our findings also lend additional support that acute increases in prolactin have no effect on the renin-angiotensin-aldosterone system in man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790402     DOI: 10.1159/000179353

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Effect of antenatal administration of thyrotrophin releasing hormone on fetal flow velocity waveforms.

Authors:  R Bajoria; K D Stagiannis; N M Fisk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

2.  The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.

Authors:  N J Coupland; J E Bailey; P Glue; D J Nutt
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

3.  Presence of brown adipose tissue in an adolescent with severe primary hypothyroidism.

Authors:  Mimi S Kim; Houchun H Hu; Patricia C Aggabao; Mitchell E Geffner; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.